Back to search
Autoimmune Encephalitis (AE)
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Autoimmune Encephalitis (AE) trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Autoimmune Encephalitis (AE) trials you may qualify forThis study is an open-label, exploratory, prospective clinical trial with dose escalation(according to "3+3" design), to evaluate the safety and tolerability of…
This single-arm, open-label investigator-initiated trial (IIT) evaluates the safety, tolerability, pharmacokinetics, pharmacodynamics, and efficacy of RD06-05 i…
This study aims to evaluate the effectiveness of \[18F\]-DPA-714 PET imaging in detecting neuroimmune activity in patients with autoimmune encephalitis (AE). Th…
Autoimmune encephalitis (AE) is a potentially life-threatening inflammation of the central nervous system (CNS) and constitutes 20%-30% of encephalitis cases in…